BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2356535)

  • 1. [Characteristics of the course of scleroderma in diabetes mellitus].
    Khamaganova IV
    Sov Med; 1990; (2):72-6. PubMed ID: 2356535
    [No Abstract]   [Full Text] [Related]  

  • 2. [The different clinical variants of scleroderma in diabetics].
    Khamaganova IV
    Ter Arkh; 1989; 61(10):70-3. PubMed ID: 2609276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physical factors in the pathogenetic therapy of children with scleroderma].
    Popik GS; Riabova TV; Martynovets LV; Kolesnikova TV
    Vopr Kurortol Fizioter Lech Fiz Kult; 1990; (4):46-8. PubMed ID: 2275105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salazopyrin (azulfidine) treatment in scleroderma.
    Dover N
    Isr J Med Sci; 1971 Nov; 7(11):1301-3. PubMed ID: 4400695
    [No Abstract]   [Full Text] [Related]  

  • 5. [The clinical heterogeneity of the scleroderma group of diseases].
    Guseva NG
    Ter Arkh; 1992; 64(8):109-12. PubMed ID: 1440384
    [No Abstract]   [Full Text] [Related]  

  • 6. Other rheumatic diseases in adolescence. Dermatomyositis, scleroderma, overlap syndromes, systemic vasculitis, and panniculitis.
    Hom C; Ilowite NT
    Adolesc Med; 1998 Feb; 9(1):69-83, vi. PubMed ID: 10961253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphological changes in the skin in scleroderma in the process of treatment with unithiol].
    Dubinskiĭ AA; Tseraidis GS; Guĭda PP; Petrusenko EA; Babykina EA
    Vrach Delo; 1978 Oct; (10):112-4. PubMed ID: 716343
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dynamics of hydroxyproline content as the indicator of the severity of the course and the effectiveness of treatment of focal scleroderma].
    Fedorova EG; Lashmanova AP
    Vestn Dermatol Venerol; 1978 Dec; (12):18-22. PubMed ID: 570330
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical pearl: Scleroderma-like skin changes in patients with diabetes mellitus.
    Yosipovitch G; Loh KC; Hock OB
    J Am Acad Dermatol; 2003 Jul; 49(1):109-11. PubMed ID: 12833019
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trafuril reaction in scleroderma].
    Urban J
    Przegl Dermatol; 1976; (6 Suppl):367-9. PubMed ID: 1032188
    [No Abstract]   [Full Text] [Related]  

  • 11. [Histomorphologic and histochemical changes in the skin during the treatment of scleroderma].
    Sych LI; Trofimova LIa
    Vestn Dermatol Venerol; 1971; 45(3):22-6. PubMed ID: 5122538
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic action of coagulation factor XIII in scleroderma. 20 cases].
    Thivolet J; Perrot H; Meunier F; Bouchet B
    Nouv Presse Med; 1975 Nov; 4(39):2779-82. PubMed ID: 1105424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized scleroderma evolving into systemic sclerosis.
    Rossi P; Fossaluzza V; Gonano L
    J Rheumatol; 1985 Jun; 12(3):629-30. PubMed ID: 4045867
    [No Abstract]   [Full Text] [Related]  

  • 14. [General and local hormonal therapy in scleroderma].
    Dobrescu A; Petrescu Z; Martinescu E; Costinescu M; Vasilca A; Popescu E; Rotaru L; Tăranu T; Pavelescu DM
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):145-9. PubMed ID: 3393746
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic effectiveness of ultrasonics and lidase phonophoresis in various forms of scleroderma].
    Didenko IG
    Vestn Dermatol Venerol; 1978 Jun; (6):76-9. PubMed ID: 354249
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of piascledine treatment of scleroderma].
    Szczepański A; Dabrowska H; Moskalewska K
    Przegl Dermatol; 1975; 62(4):555-8. PubMed ID: 1162105
    [No Abstract]   [Full Text] [Related]  

  • 17. Acid-fast bacteria in scleroderma and morphea.
    Cantwell AR; Kelso DW
    Arch Dermatol; 1971 Jul; 104(1):21-5. PubMed ID: 5120159
    [No Abstract]   [Full Text] [Related]  

  • 18. [Madecassol in the treatment of scleroderma (preliminary study)].
    Szczepański A; Dabrowska H; Blaszczyk M
    Przegl Dermatol; 1974; 61(5):701-3. PubMed ID: 4419170
    [No Abstract]   [Full Text] [Related]  

  • 19. [Piascledine in the treatment of scleroderma].
    Szczepański A; Dabrowska H; Moskalewska K
    Przegl Dermatol; 1974; 61(4):525-7. PubMed ID: 4849404
    [No Abstract]   [Full Text] [Related]  

  • 20. [The course of scleroderma following treatment with carnitin].
    Nitzschner H
    Dermatol Monatsschr; 1974 Jul; 160(7):592-6. PubMed ID: 4411133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.